Patrick Crutcher active positions
| Companies | Position | Start | End |
|---|
Career history of Patrick Crutcher
Former positions of Patrick Crutcher
| Companies | Position | Start | End |
|---|---|---|---|
| AVALO THERAPEUTICS, INC. | Corporate Officer/Principal | - | 2019-10-31 |
Ichorion Therapeutics, Inc.
 Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ichorion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of treatments for rare diseases. It focuses on a pipeline of genetically-targeted therapies for inherited metabolic disorders known as Inborn Errors of Metabolism. The company was founded by Stephen Thomas on July 7, 2017 and is headquartered in New York, NY. | Chief Executive Officer | 2017-06-30 | 2018-08-31 |
| Chairman | 2017-06-30 | 2018-08-31 |
Training of Patrick Crutcher
| University of Illinois | Undergraduate Degree |
| University of California, Los Angeles | Graduate Degree |
Statistics
International
| United States | 5 |
Operational
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 1 |
| Chairman | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| AVALO THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Ichorion Therapeutics, Inc.
Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ichorion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of treatments for rare diseases. It focuses on a pipeline of genetically-targeted therapies for inherited metabolic disorders known as Inborn Errors of Metabolism. The company was founded by Stephen Thomas on July 7, 2017 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Patrick Crutcher
- Experience
